FEMPRO 2.5 MG 10 TABLETS | Letrozole Aromatase Inhibitor Medicine
FEMPRO 2.5 MG 10 TABLETS contain Letrozole 2.5 mg, a prescription aromatase inhibitor used for hormone receptor-positive breast cancer treatment in postmenopausal women under medical supervision.
FEMPRO 2.5 MG 10 TABLETS
FEMPRO 2.5 MG TABLETS (Letrozole 2.5 mg): Comprehensive Guide and Benefits
Introduction to FEMPRO 2.5 MG TABLETS
Aromatase Inhibitor for Hormone-Dependent Breast Cancer Management
FEMPRO 2.5 MG TABLETS contain Letrozole 2.5 mg, a prescription hormonal anticancer medicine belonging to the aromatase inhibitor class. It is primarily used for the treatment of hormone receptor-positive breast cancer in postmenopausal women.
Letrozole works by reducing estrogen production in the body. Since some breast cancers depend on estrogen for growth, lowering estrogen levels may help slow or control the progression of hormone-sensitive cancer cells.
Prescription Status: Prescription-only medicine. Use strictly under the supervision of an oncologist or qualified healthcare professional.
Key Benefits of FEMPRO 2.5 MG TABLETS
Helps manage hormone receptor-positive breast cancer in postmenopausal women.
Reduces estrogen production by inhibiting aromatase enzyme activity.
May help slow the growth of estrogen-dependent cancer cells.
Used as adjuvant, extended adjuvant, or advanced breast cancer therapy as prescribed.
Composition
Active Ingredient:
Letrozole – 2.5 mg
Dosage Form:
Film-coated Oral Tablet
Pack Size:
10 Tablets
Drug Class:
Aromatase Inhibitor
Hormonal Anticancer Agent
Manufacturer/Marketer:
Cipla Ltd.
How FEMPRO 2.5 MG Works
FEMPRO contains Letrozole, which inhibits the aromatase enzyme responsible for converting androgens into estrogen.
By reducing estrogen levels:
Hormonal stimulation of estrogen-sensitive breast cancer cells decreases.
Cancer cell growth may be slowed in hormone-dependent breast cancer.
Usage Instructions
Take FEMPRO 2.5 MG TABLETS exactly as prescribed by your doctor.
Usually taken once daily, with or without food.
Swallow the tablet whole with water.
Take it at the same time each day for consistent effects.
Do not stop treatment without consulting your healthcare provider.
Continue treatment for the duration recommended by your oncologist.
Medicinal Advantages
Hormone Receptor-Positive Breast Cancer Management
FEMPRO helps reduce estrogen availability, which may support treatment of estrogen-dependent breast cancer in appropriate patients.
Postmenopausal Breast Cancer Therapy
Letrozole is commonly used in postmenopausal women for:
Early hormone receptor-positive breast cancer.
Extended adjuvant therapy after previous treatments.
Advanced hormone-dependent breast cancer.
Targeted Hormonal Action
Unlike traditional chemotherapy, Letrozole works by targeting estrogen production pathways involved in hormone-sensitive cancer growth.
Mechanism of Action
Letrozole selectively inhibits the aromatase enzyme, blocking the conversion of androgens into estrogens in peripheral tissues.
Reduced estrogen levels limit hormonal stimulation of estrogen receptor-positive breast cancer cells, helping slow their growth.
Off-Label Uses
Letrozole may be prescribed by specialists for certain fertility-related conditions, such as ovulation induction, based on individual patient assessment.
Any off-label use should only be undertaken under medical supervision.
Expert Advice
Take FEMPRO regularly as prescribed for maximum benefit.
Inform your doctor about osteoporosis, liver disease, or high cholesterol.
Maintain regular follow-up appointments and recommended monitoring.
Report unusual bone pain, fractures, or severe symptoms promptly.
Precautions
Bone Health
Long-term estrogen reduction may increase the risk of decreased bone mineral density. Your doctor may recommend bone health monitoring.
Pregnancy
FEMPRO should not be used during pregnancy unless specifically advised by a specialist, as it may harm fetal development.
Liver Problems
Inform your doctor if you have liver disease, as dose adjustments or monitoring may be required.
Menopausal Status
Letrozole is primarily indicated for postmenopausal women in breast cancer treatment.
Drug Interactions
Inform your doctor if you are taking:
Estrogen-containing medicines.
Hormonal therapies.
Tamoxifen or other anticancer medicines.
Medicines affecting liver enzymes.
Possible Side Effects
Common side effects may include:
Hot flashes.
Joint pain.
Muscle pain.
Fatigue.
Increased sweating.
Headache.
Nausea.
Bone or joint discomfort.
Seek medical advice if you experience severe bone pain, allergic reactions, chest pain, or unusual symptoms.
Storage Instructions
Store at room temperature.
Keep tablets in the original packaging.
Protect from moisture and direct sunlight.
Keep away from children.
Frequently Asked Questions (FAQs)
Q: What is FEMPRO 2.5 MG used for?
A: FEMPRO 2.5 MG contains Letrozole and is used mainly for treating hormone receptor-positive breast cancer in postmenopausal women.
Q: What is the active ingredient in FEMPRO 2.5 MG?
A: Each tablet contains Letrozole 2.5 mg.
Q: Is FEMPRO a chemotherapy medicine?
A: No. FEMPRO is a hormonal anticancer medicine that works by reducing estrogen production.
Q: Can FEMPRO be stopped suddenly?
A: Do not stop FEMPRO without medical advice, as it may affect the effectiveness of cancer treatment.
Q: Does FEMPRO cure breast cancer?
A: FEMPRO is used as part of breast cancer management to help control hormone-sensitive cancer; outcomes depend on individual disease factors and overall treatment plans.
Product Tags
FEMPRO 2.5 MG 10 TABLETS, Letrozole 2.5 mg Tablet, Aromatase Inhibitor Medicine, Hormonal Cancer Therapy, Breast Cancer Treatment Medicine, Estrogen Blocking Therapy, Oncology Prescription Medicine, Cipla Letrozole Tablet.
